Mortality and Its Predictors among HIV Infected Patients Taking Antiretroviral Treatment in Ethiopia: A Systematic Review

Table 2

Mortality indicators.

Sr. number	Author, year of publication	Median follow-up period	Death,; (%)	Mortality incidence density/100 PY	Mean survival time (95% CI)	Mortality at each period
						First 3 months	First 6 months	First 12 months
(1)	Hambisa MT et al., 2013	47 months	30 (7.2%)	1.89	NR	NR	17 (56.7%)	21 (70%)
(2)	Tsehaineh B. et al., unpublished	40 months	144 (17.3%)	NR	63.7 months (61.1–66.3)	70 (48.6%)	99 (68.8%)	NR
(3)	Setegn et al., 2015	NR	120 (5.9%)	2.03	34.9 months (33.8–35.9)	NR	NR	78 (65%)
(4)	Biadgilign S. et al., 2012	NR	86 (5.6%)	2.03	NR	NR	NR	63 (73.3%)
(5)	Kassa A. et al., 2012	NR	291 (6.9%)	2.8	NR	NR	166 (57%)	NR
(6)	Seyoum D. et al., 2017	NR	66 (14.5%)	5.3	34 months (22.8–42.0)	NR	NR	40 (60.6%)
(7)	Damtew B. et al., 2015	60 months	87 (11.1)	5.15	20.7 months	49 (56.3%)	NR	NR
(8)	Alemu AW and Sebastian MS, 2010		28 (10.3%)	7	NR	NR	NR	NR
(9)	Ayalew et al., 2014	NR	92 (14.1%)	NR	41.8 months (40.61–43.00)	NR	NR	NR
(10)	Ahunie MA and Ebrahim EA	NR	35 (5.0%)	1.5	NR	NR	NR	NR
(11)	Abebe N et al., 2014	NR	261 (40.8%)	10.74	NR	NR	NR	NR
(12)	Tadesse K et al., 2014	32 months	46 (8.9%)	3.2	NR	NR	NR	27 (59%)
(13)	Bedru A. and worku A, unpublished	34 months	360 (33.6%)	NR	NR	200 (55.6%)	NR	NR
(14)	Mengesha S et al., 2014	34 months	37 (9%)	3.8	39 months	22 (59.5%)	NR	NR
(15)	Moshago T et al., 2012	NR	159 (5.9%)	0.2	89 months	NR	NR	NR
(16)	Sapa et al., 2016	25 months	128 (9.2%)	3.5	NR	33 (26%)	NR	66 (52%)
(17)	Kebebew K and wencheko E, 2012	38.5 months	86 (11.7%)	NR	NR	28 (32.6%)	43 (50%)	86 (100%)

NR: not reported.